| FRIDAY, JUNE 16 |
| 11:30 AM |
12:00 PM |
Posters: Session A: (A1-A2, A4) & Session B: (B5, B7-B21) |
|
|
-
A2: Oxidative burst and cytokine expression in patients and healthy volunteers receiving hyperbaric oxygen: A pilot study: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
|
- A4: Early single-session hyperbaric oxygen therapy attenuates post cardiac arrest renal injury in asphyxial cardiac arrest rat model: YS Lee, MD
|
- B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD
|
- B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay C. Buckey, M.D.
|
- B8: Pilot evaluation of long-term follow-up for the Multicenter Registry for Hyperbaric Oxygen Therapy: Jay C. Buckey, M.D.
|
- B9: Multicenter Hyperbaric Outcomes Registry: 2022 review: Jay C. Buckey M.D.
|
- B10: Retrospective assessment of the “Duke Mods”, An approach to reducing hyperbaric tender decompression sickness risk for multiplace chamber operations: M. Claire Ellis
|
- B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning: Yong Sung Cha, MD, PhD
|
- B12: Utility of echocardiographic global longitudinal strain to predict myocardial fibrosis in patients in carbon monoxide poisoning: Yong Sung Cha, MD, PhD
|
- B13: Hyperbaric oxygen therapy regimens, treated conditions, and adverse effect profile: A UHMS survey study:
Matteo Laspro, BA
|
- B14: Perception and availability of hyperbaric oxygen therapy as a treatment modality for carbon monoxide poisoning among emergency medicine physicians: Tyler Connely, BS
|
- B15: Early hyperbaric oxygen therapy is associated with favorable outcome in iatrogenic cerebral arterial gas embolism: Individual patient data meta-analysis of observational studies: Robert P. Weenink, CAPT (Navy), MD, PhD
|
- B16: Hyperbaric oxygen therapy chamber supervision across the usa: how often do practitioners supervise more than one HBO2 simultaneously?: Helen Gelly, MD, FUHM, UHM/ABPM
|
- B17: Inflammatory response profiles in COVID-19 patients treated with hyperbaric oxygen therapy compared with best practice: Anders Kjellberg, MD
|
- B18: The objective effects of Hyperbaric oxygen therapy on the chronic non-healing wounds using digital planimetry:
Mor Rittblat, MD
|
- B19: Severe digital frostbite treated with hyperbaric oxygen therapy: Jessica Hoge, MD
|
- B20: Effectiveness of 6-week follow-up after hyperbaric oxygen treatment for carbon monoxide poisoning in identifying delayed neurological sequelae and referral to neurological services: Dallin Lindahl, MD, MS
|
- B21: Oxygen concentration in and around a monoplace hyperbaric chamber after emergency decompression and defibrillation safety: Justin P. Meunier, MD
|
| |
|
ORAL PRESENTATIONS |
| 2:00 PM |
2:10 PM |
B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning; Yong Sung Cha, MD, PhD |
| 2:10 PM |
2:20 PM |
B18: The objective effects of Hyperbaric oxygen therapy on the chronic non-healing wounds using digital planimetry;
Mor Rittblat, MD |
| 2:20 PM |
2:30 PM |
A3: Sex differences in susceptibility to central nervous system oxygen toxicity: Matthew S. Makowski, MD |
| 4:30 PM |
4:40 PM |
B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD |
| 4:40 PM |
4:50 PM |
B6: A Randomized Trial of Preoperative Hyperbaric Oxygen (HBOT) Before Pancreaticoduodenectomy: Enrico Camporesi, MD |
| 4:50 PM |
5:00 PM |
B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay Buckey, MD |
| 5:00 PM |
5:30 PM |
Posters: Session B: (B22-B41) |
- B22: U.S. multicenter randomized controlled trial of hyperbaric oxygen for COVID-19 patients with moderate to severe hypoxemia: Enoch Huang, MD, MPH&TM, FUHM
|
- B23: Hyperbaric oxygen treatment + icing achieves the effects of icing and thermotherapy simultaneously in a rat acute skeletal muscle contusion model: Takashi Hoshino MD, PhD
|
- B24: Dartmouth Registry Annual Report: A look at treatment of conditions outside of UHMS indications:
Hideaki Leo Tanaka, MD, FACEP
|
- B25: Feasibility and FDA evaluation for a Phase II Clinical Trial on efficacy of hyperbaric oxygen therapy for post COVID condition: Hideaki Leo Tanaka, MD, FACEP
|
- B26: Risk factors for complications of orthopedic trauma – post hoc analysis of the HOLLT Study data: Ian Millar MBBS
|
- B27: Assessing hyperbaric and undersea medicine physicians prescribing practices regarding HBO2 for non-emergent indications in patients who smoke: Kaighley Brett, MD
|
- B28: A randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2):
Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
|
- B29: Carbon monoxide poisoning from being towed behind a boat: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
|
- B30: A 19-year retrospective analysis of hyperbaric oxygen seizures : Geness Koumandakis, RRT
|
- B31: Does slow and steady win the race? Consideration on optimal compression time: Samuel Hawkins, MD
|
- B32: CO-oximetry in the emergency department: Jeffrey Cooper, MD
|
- B33: Hyperbaric oxygen therapy for renal abscess: A case series: Kazuki Yanagida, MD
|
- B34: Current trends in hyperbaric oxygen therapy use in central retinal artery occlusion management in US hyperbaric facilities: William Toppen, MD
|
- B35: Neuropsychological outcomes in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury: Rosemary Ziemnik, MS
|
- B36: Safety and adverse events in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2): Rosemary Ziemnik, MS
|
- B37: Hyperbaric treatment improves late effects of radiation on the chest wall: Joan Chou, MD
|
- B38: Successful placement and activation of artificial urethral sphincter for urinary incontinence after completing adjunctive hyperbaric oxygen therapy for radiation cystitis: Dallin Lindahl, MD, MS
|
- B39: Myodesopsia after hyperbaric oxygen therapy: An unusual case report: Jiho Lee, PhD
|
- B40: Hyperbaric oxygen therapy for thalamic pain syndrome: Peter Lennox MD
|
- B41: HBO2 for wound in irradiated field leads to avoidance of surgery: A case report: Jayanth Adusumalli, MBBS, MPH
|
| SATURDAY, JUNE 17 |
| |
|
ORAL PRESENTATIONS |
| 10:30 AM |
10:40 AM |
C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis; Emmanuel Dugrenot, PhD |
| 10:40 AM |
10:50 AM |
C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms:
Arian Azarang, PhD |
| 10:50 AM |
11:00 AM |
C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions:
Edward Ashworth, PhD |
| 11:00 AM |
11:10 AM |
C52: Elevations of inflammatory biomarkers in closed circuit SCUBA divers parallel those in DCS models: Stephen Thom, MD |
| 11:10 AM |
11:20 AM |
C53: A Novel Method for Observing Gaseous Nitrogen In Vivo and Ex Vivo Using Radioactive Nitrogen-13: Edward Ashworth, PhD |
| 11:20 AM |
11:30 AM |
C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS |
| 11:30 AM |
12:00 PM |
Posters: Session B: (B42-B51) & Session C: (C54-C62) |
- B42: Use of hyperbaric oxygenation therapy for Cyclophosphamide-Induced Hemorrhagic Cystitis. A case report with a call for awareness and advocacy: Denise Nemeth, OMS-II, MPAS, PA-C
|
- B43: CT perfusion patterns in iatrogenic cerebral arterial gas embolism: a retrospective cohort study: R.A. Fakkert, MD
|
- B44: Hyperbaric oxygen therapy for cerebral radiation necrosis secondary to stereotactic radiation: A Case Series:
Jeffrey Cooper, MD
|
- B45: Incidence of COVID-19 history among patients with ISSNHL treated with hyperbaric oxygen therapy:
Jacek Kot, MD, PhD
|
- B46: Hyperbaric oxygen therapy for pyoderma gangrenosum as a new treatment strategy: HOTPANTS trial: Ellen C. Kop, MD, PhD
|
- B47: A research on the application of hyperbaric oxygen treatment for the treatment of sepsis: Xuyuan Kuang, MD, PhD
|
- B48: Delayed encephalopathy of tramadol overdoses related CHANTER syndrome successfully treated with consecutive hyperbaric oxygen therapy: Naoto Jingami, MD, PhD
|
- B49: Hyperbaric oxygen for long-covid condition: Joshua J. White, JD
|
- B50: Why wound you heal?: Liz Eshleman, MSN, FNP-C
|
- B51: E-cigarette explosion leading to oropharyngeal cancer: Jessica Coffendaffer, MSN, APRN, FNP-C
|
- C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS
|
- C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis: Emmanuel Dugrenot, PhD
|
- C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms:
Arian Azarang, PhD
|
- C57: Automated grading of venous gas emboli in Doppler ultrasound achieves human inter-rater agreement performance: A log-scale mel spectrogram-based deep learning approach: Arian Azarang, PhD
|
- C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions:
Edward Ashworth, PhD
|
- C59: A PET compatible hyperbaric chamber for rodents to enable temporal and spatial monitoring of tissue nitrogen gas (nitrogen-13) in vivo: Edward Ashworth, PhD
|
- C60: Pathophysiology of cutis marmorata in porcine decompression sickness: Aashay Patel, BSPH
|
- C61: Stress and inflammation salivary analytes collected from standardized dives: Rhiannon Brenner
|
- C62: Measuring whole-body inert gas turnover: Oscar Plogmark, MD, PhD student
|
| |
|
ORAL PRESENTATIONS |
| 3:00 PM |
3:10 PM |
D65: Preliminary evidence that fourteen days of apnea and hypoxia exposures reduces circulating pro-inflammatory microparticles: Zachary Schlader, PhD |
| 3:10 PM |
3:20 PM |
D66: Analysis of chest radiographs from navy SEAL (Sea Air Land) candidates developing pulmonary symptoms while swimming: Two different patterns of what previously has been described as pulmonary: Peter Lindholm, MD, PhD |
| 3:20 PM |
3:30 PM |
D67: Arterial PCO2 during submersed prone exercise suggests attenuation of hypercapnia after respiratory muscle training: Nicholas Bartlett |
| 5:00 PM |
5:30 PM |
Posters: Session C: (C63-C64) & Session D: (D68-D83) & Session F: (F117) |
- C63: A quantitative approach to assess similarity between dives under the Bühlmann decompression algorithm constraints: Josh Currens, BS
|
- C64: Analysis of gas evolution in the heart, liver and kidney of turtles presenting with decompression sickness based on ultrasonography: Katherine Eltz, BS, PhD Student
|
- D68: Effects of hyperbaric exposure on perceptual-motor coordination: Nozomu Kageyama , PhD
|
- D69: Nitrous oxide consistently attenuates thermogenic and thermoperceptual responses to repetitive cold stress in humans: Maaike Iris Moes, Msc
|
- D70: Relative hypoxemia at depth during breath-hold diving investigated through arterial blood gas analysis and lung ultrasound: Gerardo Bosco, MD, PhD
|
- D71: Evaluation and follow-up of divers after COVID-19 infection: A prospective, observational study: Charlotte Sadler, MD
|
- D72: Exercise-related drops in blood oxygen saturation to diagnose marginal decompression sickness cases:
Gabriela Morales, BSE
|
- D73: DRACO 2023: DAN looks at increased gas consumption upon return to dive in divers with COVID-19 infection:
Frauke Tillmans, PhD
|
- D74: Divers treated in Townsville, Australia: Worse symptoms lead to poorer outcomes: Denise F Blake, BN, MD, FRCPC, FACEM, PGDipMedSci (DHM), Dip DHM, PhD candidate
|
- D75: Cost effectiveness of urinalyses in occupational diver clearance: William Toppen, MD
|
- D76: Sampler and proposed biological test for contaminated water at dive sites: Rachel M Lance, PhD
|
- D77: Treatment of decompression sickness at Kawashima Orthopaedic Hospital: Masayuki Kawashima, MD
|
- D78: Lack of recompression facilities for diving injuries on the Central Gulf Coast: Julio R. Garcia RN, BSN, ACHRN, WCC, FAPWCA
|
- D79: Maximal fat oxidation in relation to 20 weeks of military diver training: Clara Sjöblom MSc
|
- D80: Identifying low risk dive profiles in the Canadian Diving Data and Doppler Ultrasonic Data BASE: A retrospective review: Kaighley Brett, MD
|
- D81: Neurocognitive performance during repetitive recreational harvesting dives: Grant Dong B.S.
|
- D82: From UPTD to ESOT: Monitoring hyperoxic exposure in surface-oriented diving: Jan Risberg, MD, PhD
|
- D83: State of the art review – Cardiac fitness assessment for diving in individuals with pre-existing asymptomatic coronary artery disease: Weien Chow, MRCP, M.Med
|
- F116: Bedside fluorescence microangiography aids decision-making regarding hyperbaric oxygen therapy for a compromised flap: Jenny Thacker, MD, FACEP
|
| SUNDAY, JUNE 18 |
| |
|
ORAL PRESENTATIONS |
| 9:00 AM |
9:30 AM |
E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss, CHT |
| 9:30 AM |
9:40 AM |
E92: GO/NO GO: A tool to eliminate the guesswork in determining which items may be allowed in a hyperbaric chamber:
Jeff Mize RRT, CHT, UHMSADS |
| 9:40 AM |
9:50 AM |
E98: A solution for clinical hyperbaric facilities to easily standardize, track and document routine safety inspections: Checklist-based digital task manager: Tiffany Hamm BSN, RN, ACHRN, CWS, UHMSADS |
| 9:50 AM |
10:00 AM |
F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA |
| 2:30 PM |
2:40 PM |
E88: A Case to Support the Routine Monitoring and Analysis of Breathing Gases Provided to the BIBS Line from Vendor Provided K Cylinder Storage: John Sullivan, CHT |
| 2:40 PM |
2:50 PM |
E89: Barriers to 24/7 Availability and Emergent Clinical Capabilities of Hyperbaric Medicine Facilities: A Large-Scale Survey Study: John McGlynn, MD |
| 2:50 PM |
3:00 PM |
E90: Strengths and Weaknesses of Monoplace vs Multiplace Chambers for Hyperbaric Critical Care: Ian Millar, MBBS |
| 3:30 PM |
4:00 PM |
Posters: Session D: (D84-D87) & Session E: (E88-E97; E99-E101) & Session F: (F102-F103) |
- D84: Redefining work of breathing: Addressing modeling gaps in instantaneous flow models: Victoria Ribeiro Rodrigues, BS, PhD Student
|
- D85: Determination of tidal volume-controlled buoyancy boundaries’ impact on diver workload efficiency: Aviad Cahana, BSc
|
- D86: Crochetage pattern: An electrocardiographic warning sign for scuba divers: Sarah Crawford MD, MSc
|
- D87: Development of a model to simulate underwater physiology: Tobias Cibis, PhD Candiate
|
- E88: A case to support the routine monitoring and analysis of breathing gases provided to the BIBS Line from vendor-provided K cylinder storage: John Sullivan, CHT
|
- E89: Barriers to 24/7 availability and emergent clinical capabilities of hyperbaric medicine facilities: A large-scale survey study: John J McGlynn, MD
|
- E90: Strengths and weaknesses of monoplace vs multiplace chambers for hyperbaric critical care: Ian Millar, MBBS
|
- E91: Allowing emergency decompression for inside attendant during hyperbaric oxygen therapy: Oscar Plogmark, MD, PhD student
|
- E93: Laptop-style POCUS machines in the multiplace HBO2 chamber: Jenny Thacker, MD, FACEP
|
- E94: The development of hyperbaric medicine in Korea since 2017: Sungmin Lee, MD, PhD
|
- E95: Evaluating the function and safety of a Bluetooth™ device in the multiplace hyperbaric environment:
Andrew Melnyczenko, BSHCA, CHT
|
- E96: Evaluation of an elastomeric respirator for use in the multiplace hyperbaric environment: Heather Viste, BAN, RN
|
- E97: Effects of airway and pressure threshold resistance on fatigue and cognition in divers: Daniel Steven Williams, BSCPE, MSEE
|
- E99: Predicting tidal volume of the Zoll Z Ventilator in a hyperbaric chamber: Abigail Winn, MD
|
- E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss BS, CHT, EMT
|
- E101: How hard is it to change from lithium-ion to alkaline fuel cell in a portable device?: Tony Turner, MAICD
|
| |
|
ORAL PRESENTATIONS |
| 4:00 PM |
4:10 PM |
F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series: Olayinka David Ajayi, MD, MPH |
| 4:10 PM |
4:20 PM |
F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD |
| 4:20 PM |
4:30 PM |
F104: Acute Central Retinal Artery Occlusion from Cosmetic Filler Injection: Casey Smith, MD |
| 4:30 PM |
5:00 PM |
Posters: Session F: (F104-F116; F118-F124) |
- F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series:
Olayinka David Ajayi, MD, MPH
|
- F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD
|
- F104: Acute central retinal artery occlusion from cosmetic filler injection: Casey Smith, MD
|
- F105: New seizure disorders after carbon monoxide poisoning: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
|
- F106: Hyperbaric oxygen treatment for paracentral acute middle maculopathy: A case study: Robert Neiberger, DO
|
- F107: Atypical avascular necrosis treated with hyperbaric oxygen therapy: Cheryl Hickey, MD
|
- F108: Acute Traumatic Polymicrobial Pinna Perichondritis Treated with Hyperbaric Oxygen Therapy:
Raymond C. Shields, MD
|
- F109: Hyperbaric oxygen therapy in cases of BK virus hemorrhagic cystitis: Christopher Allen, MD
|
- F110: Case report of an intractable cough due to radiation pneumonitis treated with hyperbaric oxygen:
Gerald H. Markovitz, MD
|
- F111: Polyarteritis nodosa treated with hyperbaric oxygen therapy: Jessica Hoge, MD
|
- F112: Hyperbaric oxygen therapy for the treatment of carbon monoxide-induced delayed neurological sequelae: A case report and review of the literature: Colin Teo, MBBS
|
- F113: Successful outcome from persistent brain abscess with addition of adjunctive hyperbaric oxygen therapy:
Christopher Woodard, MB, BCH, BAO
|
- F114: Resolution of ischemic colitis with perforation, with hyperbaric oxygen treatments: Kim Wilkinson, RN-AND
|
- F115: Altitude DCS treatment options: Nathan Kwan, MAJ (Army), MD
|
- F117: Massive venous gas embolism in a diver post-COVID: Jenny Thacker, MD, FACEP
|
- F118: Acute cognitive impaired diver hyperbaric treatment effect: A case series: Ian Kirby, MD, CCFP, UHM
|
- F119: Case report of PFO closure in an occupational diver after Type II DCS: Kaighley Brett, MD
|
- F120: Immersion pulmonary edema: Not limited to a specific UBA: James E. Breuer, MD
|
- F121: Alternate teatment For AGE when USN TT6 not feasible: Shane Day, DO, MPH, MS, CP
|
- F122: Good result of hyperbaric oxygen therapy in a 50 year old male with chronic therapy refractair osteomyelits on the left foot, with diabetes mellitus and sensomotoric axonal polyneuropathy: Ellen C. Kop, MD, PhD
|
- F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA
|
- F124: Unusual Presentation of Diplopia and Oxygen Toxicity Symptoms after 100% Oxygen Closed Circuit Rebreather Diving: A Case Report: Chiew Wenqi, MBBS
|
